Virtual Medicinal Product (VMP) - Cytarabine (liposomal) 50mg/5ml suspension for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Cytarabine (liposomal) 50mg/5ml suspension for injection vials Start Date 21-06-2007 End Date
Previous Name Previous Name Cytarabine 50mg/5ml suspension for injection vials Start Date 31-07-2006 End Date 20-06-2007
Abbreviated Name Abbreviated Name Cytarabine (liposomal) 50mg/5ml inj vials Start Date 01-05-2009
Previous Abbreviated Name Cytarabine (liposomal) 50mg/5ml susp for inj vials Previous Start Date 21-06-2007 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
5
UDFS UOM
ml
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intrathecal
Form
Suspension for injection
Ontology Form/Route
suspensioninjection.intrathecal
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
L01BC01
BNF Start Date End Date
Current BNF 08010300 Start Date 04-04-2022 End Date
Previous BNF 08010300 Start Date 14-12-2006 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
7591711000001106 24-06-2004

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Cytarabine (liposomal) Based on Ingredient Substance 10 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial